Navigation Links
Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego
Date:7/10/2014

ent and to prevent illicit acts such as counterfeiting, diversion, and economic adulteration which threaten the safety of the drug supply,” is the greatest challenge facing the biotech industry and we can make a huge difference”, remarked Martin Van Trieste, Senior Vice President of Quality Assurance at Amgen.

The exchange of issues and answers relating to how strategic sourcing can be leveraged by small to large companies was insightful and candid as eminent executives served on a panel. The industry leaders consisted of Isaac Young, Sr. Director Supply Chain Operations, BioMarin Pharmaceuticals; Mark Buck, Global Supply Chain and Procurement Leader, Bio-Rad Laboratories; Mary Kachinsky, Sr. Director of Strategic Sourcing, Cubist Pharmaceuticals; Paul Anderson, Sr. Director of Operations Strategy, Thermo Fisher Scientific; Prentice Curry, Vice President of Quality and Operations, Kite Pharma; and, Wayne McDonnell, Director of Advisory, PwC. The takeaways were that in the global market place, inter-dependence of trading partners in the supply chain, regulations in the emerging markets, IT systems connectivity, sustainability of the environment and safety have added challenges to achieving agility, cost reduction, quality and safety.     

Key research findings on the business landscape of healthcare logistics around the world, as well as healthcare logistics executives’ top concerns and strategies for expansion, were presented by Robin Hooker, Director of Global Strategy Healthcare Logistics at UPS.

There is extreme “pain in the supply chain of pharma, biotech and medical device industries but strategic and tactical solutions can be implemented”, declared Hooker.        

Mary Kachinsky, Senior Director of Strategic Sourcing at Cubist Pharmaceuticals shared enriching lessons in implementing a large scale information system for strategic sourcing. She was assisted by Richard Wa
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R))
2. University at Albany: Governor Cuomo Announces Israeli Biotech Company Creating New Economic Opportunity In Capital Region
3. Leading Cancer Immunotherapy Biotech Startup Announces New Investments, Leadership Appointments
4. Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase
5. 2013 Report on the International Biotechnology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2017
6. New Insights on the Decline of Research and Development in Pharma & Biotech
7. Dr. Daniel Von Hoff Joins Lixte Biotechnologys Scientific Advisory Board
8. Arcturus Therapeutics, Inc. to Present at the Biotech Showcase 2014
9. Neurotrope, Inc., to Present at Biotech Showcase 2014 in San Francisco
10. PTC Therapeutics Added to NASDAQ Biotechnology Index
11. Infinity Group Invests US$4.2 M in Green BioTech Company BotanoCap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Baltimore, MD (PRWEB) November 24, 2014 ... recruiting underrepresented patient populations into clinical trials at ... Maryland. , “Continental was created with the ... trials play a fundamental role in medical advances," ... the Tuskegee syphilis experiment to the immortal cell ...
(Date:11/24/2014)... Senior Vice President, General Manager for Clinical ... acumen Elsevier , a world-leading provider ... congratulates Diane Bartoli , Senior Vice President and ... Solutions, for being recognized in the 13 th ... Profiles in Diversity Journal ® . ...
(Date:11/22/2014)... Boston, MA (PRWEB) November 21, 2014 ... and key investors will gather on December 3rd ... Boston Biotech Conferences series. GeneticRx will take place ... Harvard Medical School and will discuss the present ... gene therapy, exon skipping, and gene editing—as well ...
(Date:11/22/2014)... 2014 The “Chiral Chromatography Columns ... Material (Metal, Glass, Plastic), by Application [GC, LC ... Forecast to 2018” analyses and studies the major ... America, Europe, Asia, and Rest of the World. ... figures spread through 135 pages and in-depth TOC ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 2Elsevier Clinical Solutions' Diane Bartoli Featured In Profiles in Diversity Journal's 13th Annual Women Worth Watching Issue 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... invivodata, inc., ( http://www.invivodata.com ... reported outcomes (ePRO) solutions and services for ... of featured presentations at upcoming international events ... and its scientific and regulatory consulting division, ...
... a subsidiary of,Eisai Corporation of North America, today ... study of its MORAb-009 monoclonal antibody in,mesothelioma. The ... and cisplatinum, as a first-line treatment for patients ... objective of the study is to assess the ...
... Accera, Inc., a biotechnology company delivering breakthrough ... launched Axona(TM) in the United States for Alzheimer,s ... for the clinical dietary management of the metabolic ... it targets the metabolic deficiencies and imbalances associated ...
Cached Biology Technology:invivodata and PRO Consulting to Present at International Industry Events 2invivodata and PRO Consulting to Present at International Industry Events 3Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 2Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 3Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimer's Disease 4
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... in microcontroller (MCU) and touch technology solutions, today launched ... sensors with the widest V cc range ... temperature accuracy and faster I 2 C bus communication ... serial EEPROM memory making them ideal for consumer, industrial, ...
(Date:11/18/2014)... 2014   EyeLock Inc. , a market ... MorphoTrust USA (Safran), a leading U.S. provider ... strategic partnership to offer comprehensive biometric identity solutions ... airport screening and financial services markets. ... consumers through a nationwide network of 1,100 IdentoGO® ...
(Date:11/10/2014)... began appearing on U.S. store shelves in early 2010, ... since. The small packets can be tossed into a ... liquid or powder. The convenience, though, has come with ... researchers at Nationwide Children,s Hospital found that from 2012 ... 17,230 children younger than 6 years of age swallowing, ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Study finds laundry detergent pods, serious poisoning risk for children 2
... within the eye and dispense medication accordingly could ... by biomedical engineers at UC Davis. Tingrui ... researcher Hailin Cong started with a material called ... powdered silver on the PDMS in a precise ...
... the lowliest bacterium use molecules to communicate. Some chemicals ... still others are used to attract members of the ... have now found a rare kind of signaling molecule ... serves a dual purpose, working as both a population-control ...
... as a universal means of communication. For example, a sudden ... the brain or cause a heart cell to beat. A ... sense and respond to the variety of calcium fluctuations within cells. ... a team of biomedical engineers at the Johns Hopkins School ...
Cached Biology News:Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes 2Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes 3Like eavesdropping at a party 2
Mouse monoclonal antibody raised against a partial recombinant TPR. NCBI Entrez Gene ID = TPR...
... for 1,464 array sample elements. , , ,Includes:, ... BSA in PBS (10X): 50 ml , INDIA HisProbe ... packs , 10% Tween-20: 2 x 10 ml ampules ... ml , SuperSignal West Pico Stable Peroxide: 2 ...
... system, 100-120 V, is used for biolistic ... handheld device employs an adjustable helium pulse ... gold microcarriers from the inner wall of ... cells. This system has a 2 square-centimeter ...
... Mouse polyclonal antibody raised ... Immunogen: ... 94 a.a) partial recombinant protein ... Accession Number: NM_024721 ...
Biology Products: